Lawrence H. Boise
Cell death, BCL-2 family, apoptosis, pharmacology, therapeutic response, drug resistance

Lisa Butler
Hormone receptors, lipid metabolism, patient-derived cancer models, small molecule inhibitor responsiveness, biomarkers

George Calin
Non-coding RNA, microRNAs, DNA damage and repair, transcriptomics, Toll-like receptors, RNA-based therapeutics and biomarkers

Jason S. Carroll
Epigenetics and epigenomics, functional genomics, transcription, nuclear receptors and hormone receptors

Scott Dehm
Genomics, RNA processing, nuclear and hormone receptors, transcription and gene expression regulation, transcription factor therapeutic targeting, therapeutic resistance

J. Alan Diehl
Cell cycle and checkpoints, cell signaling, protein turnover, metabolism, cellular stress responses

Kojo Elenitoba-Johnson
Lymphoma, Signal transduction, protein-protein interactions, proteomics, genomics

Sumin Kang
Kinase signaling, cell signaling, metabolism, post-translational modifications, metastasis, small molecule inhibitors, therapeutic resistance

W. Lee Kraus
Transcription factors, gene regulation and transcription, functional genomics, epigenetics and epigenomics, hormone signaling, PARPs and ADP-ribosylation

Steven B. McMahon
Oncogenes and tumor suppressors, gene regulation and transcription, cell signaling, cell cycle, cell death, epigenetics and chromatin biology

Ed Reznik
Bioinformatics, genomics, metabolism, mitochondrial genetics

Toshiyasu Taniguchi
DNA damage and repair, BRCA family, BRCA reversion mutations, genome maintenance, drug resistance, Fanconi anemia

Jean Y.J. Wang
Carcinogenesis, cell cycle, cell death, cell signaling, drug targets and mechanisms, drug resistance mechanisms, synthetic lethality